Clinical Trial

Human Genes and Microbiota in Early Life

Study acronym: HuGME
Recruiting
View on ClinicalTrials.gov →
Summary
The long-term goal of the Human Genes and Microbiota in Early Life (HuGME) is to explore the short- and long-term effects of maternal microbiota during pregnancy and the microbiota colonization of their offspring early in life and their interaction with the host on maternal-offspring health consequences in later life in the born in Guangzhou cohort study in China. Identification of the effect of microbiota in early life, as well as environmental factors and microbe-host interaction, will lead to a better understanding of disease pathogenesis and provide a foundation for targeted mechanistic investigation into the consequences of microbial-host crosstalk for long-term health. It also can result in new strategies to predict and prevent diseases in later life.
Trial Details
NCT Number NCT06926166
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions Host and Microbiome, Pregnancy Outcomes, Pregnancy Complications, Neurodevelopmental Disorders, Immune Development, Childhood Obesity, Type 2 Diabetes
Enrollment 20,000 participants
Start Date 2019-04-01
Primary Completion 2038-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-13